Cytarabine
OSU-24309
Phase 2 small_molecule active
Quick answer
Cytarabine for Acute Myeloid Leukemia is a Phase 2 program (small_molecule) at Kura Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kura Oncology
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active